Swiss generic and biosimilar medicines company Sandoz (SWX: SDZ) today announced that Wyost (denosumab) and Jubbonti ...

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing ...

Arcus Biosciences (NYSE: RCUS) is setting the stage for a high-stakes Phase III showdown in kidney cancer, after early ...

Half Year Results/Half Year ReportBRAIN Biotech AG reports final half-year figures for fiscal year 2024/25 28.05.2025 / 07:30 CET/CESTThe issuer is solely responsible for the content of this ...

Excerpted with permission from Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives ...

The study abstracts were published on the ASCO website on May 22, 2025 (CDT), with key highlights summarized below: ...

We are thrilled to attend NYSCC Suppliers' Day to showcase our industry solutions, emphasizing performance in personal care ...

SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), and ...

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

TCI Biotech, a global leader in health and wellness innovation, will mark a major milestone at Vitafoods Europe 2025 with a dynamic showcase of its rebranded identity, next-gen CDMO+ model, and ...